Perpetual Medicines

• 01/12/2023
• Seed
• $8,000,000

About Perpetual Medicines

Perpetual Medicines is a fully integrated computational peptide therapeutics company that aims to build the next-generation peptide drug discovery engine. Perpetual Medicines’ platform will combine leading-edge methods in computational physics including MD simulation, FEP, and quantum chemistry with next-generation AI technologies to predict numerous peptide properties with supreme accuracy. We will also couple this “dry” platform with large-scale synthetic laboratory using state-of-the-art biophysical and chemistry methods for high-throughput peptide synthesis & experimentation. Our vision is to disrupt the enormous 40bn-a-year peptide drug market by heralding in a new renaissance in peptide discovery, design & development.

---

---